je.st
news
Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher
2014-10-25 17:46:08| Biotech - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tags: higher
charge
leading
jim
Category:Biotechnology and Pharmaceuticals